Therma Bright Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TBRIF research report →
Price Chart
About the company
Based in Toronto, Canada, Therma Bright Inc. , established in 2001 and formerly known as The Jenex Corporation until its rebranding in 2018, specializes in the creation and commercialization of a diverse portfolio of medical and consumer health devices. Their offerings include rapid diagnostic tests for COVID-19, such as AcuVid, which screens for both antigens and antibodies.
- CEO
- Roberto Fia
- IPO
- 2021
- Employees
- 5
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on TBRIF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.20M
- P/E
- -0.73
- PEG
- 0.00
- P/S
- 22.55
- P/B
- -1.59
- EV/EBITDA
- -0.78
- Div Yield
- 0.00%
- Gross Margin
- 49.03%
- Op Margin
- -906.32%
- Net Margin
- -2951.53%
- ROE
- 234.23%
- ROIC
- 65.14%
Latest fiscal year · YoY change
- Revenue
- $80.27K+207.9%
- Gross Profit
- $-26,655-204.7%
- Op Income
- $-1,276,079
- Net Income
- $-3,134,579-27.9%
- EPS
- $-0.06-616.7%
- OCF Growth
- +89.5%
- FCF Growth
- +89.5%
- 52W High
- $0.09
- 52W Low
- $0.03
- 50D MA
- $0.04
- 200D MA
- $0.04
- Beta
- 1.13
- RSI (14)
- 44
- Avg Volume
- 1.82K
No earnings-call transcripts are available for TBRIF yet.
- Free Float
- 85.7%
- Shares Outstanding
- 61.25M
- Float Shares
- 52.46M
Our TBRIF coverage
Recent articles, reports, and earnings notes.
No research on TBRIF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TBRIF report →Therma Bright Inc. Completes Debt Settlements
newsfilecorp.com · Jul 30
Therma Bright Announces Expanded U.S. Orders for Venowave and Mobilizes Supply Chain for Upcoming Sales Volume
newsfilecorp.com · Jun 23
Therma Bright Announces Follow-On Order from Horizon Health as Venowave(TM) Gains Traction in U.S. Vascular Markets
newsfilecorp.com · May 5
Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually
newsfilecorp.com · Mar 31
Therma Bright Grants Stock Options
newsfilecorp.com · Mar 13
Therma Bright Portfolio Update: Inretio Successfully Completes First-in-Human Cohort for PREVA(TM) Stroke Platform; Targets 2026 U.S. FDA Trial
newsfilecorp.com · Feb 10
Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med
newsfilecorp.com · Jan 20
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
feeds.newsfilecorp.com · Dec 18
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.